The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis

Abstract

Objective: There is currently no effective treatment for Japanese encephalitis, which has a high rate of morbidity and mortality. This study assessed the effectiveness of a ganciclovir, methylprednisolone, and immunoglobulin combination (TAGMIC) therapy in decreasing cognitive impairment and mortality among patients with Japanese encephalitis.Methods: We retrospectively assessed the clinical data of 31 patients diagnosed with Japanese encephalitis, who were admitted to an intensive care unit. Patients were divided into the TAGMIC and non-TAGMIC group according to their treatment regime. We compared the 60-day, 6-month, and overall mortality and survival curves between groups. We also compared Barthel Index scores, Montreal Cognitive Assessment (MoCA) scores, and diffusion tensor imaging (DTI) results.Results: There was no significant difference in the 30-day mortality rate or Kaplan–Meier survival curve between groups. The 60-day, 6-month, and overall mortality rates in the TAGMIC group were significantly reduced (P = 0.043, P = 0.018, and P = 0.018, respectively) compared with the non-TAGMIC group (0, 0, 0 vs. 31.25, 37.5, 37.5%, respectively). The 60-day, 6-month, and overall Kaplan–Meier survival curves were significantly different between groups (P = 0.020, P = 0.009, P = 0.009, respectively). There was no significant difference in the Barthel Index scores of surviving patients. Among the five patients who underwent MoCA and DTI, four had a score of 0/5 for delayed recall (no cue), while the remaining patient had a score of 2/5. All five patients were able to achieve a score of 5/5 with classification and multiple-choice prompts, and had sparse or broken corpus callosum (or other) fibre bundles.Conclusion: TAGMIC treatment can reduce mortality due to severe Japanese encephalitis. The memory loss of surviving patients is mainly due to a disorder of the memory retrieval process, which may be related to the breakage of related fibre bundles.

Clinical characteristics and short-term outcomes of Japanese encephalitis in pediatric and adult patients: a retrospective study in Northern China

“…. therapy combined with immunotherapy can reduce mortality due to severe JE (24). In the study, we compared the clinical course and treatments between both groups.…”

Treatment of Severe Japanese Encephalitis Complicated With Hashimoto’s Thyroiditis and Guillain-Barré Syndrome With Protein A Immunoadsorption: A Case Report

“…This indicates obvious activation of the patient's humoral immune response with a wide extent of organ involvement (in the brain tissue, thyroid, and peripheral nerves) and high antibody burden for prolonged long duration. The virus was suppressed by a combination of antiviral-glucocorticoid-IVIG therapy, which suppresses the immune response and neutralizes pathogenic antibodies (17). However, the appearance and progression of GBS could not be prevented.…”

Human parvovirus B19 infection in hospitalized patients suspected of infection with pathogenic microorganism

“…As nucleotide triphosphate analogs, ganciclovir can competitively bind with viral DNA polymerase and thereby preventing the replication of the virus ( Jockusch et al., 2020 ). Ganciclovir and IVIG have a good effect in treating encephalitis and GBS caused by other virus ( Miao et al., 2021 ; Zang et al., 2021 ). In this study, 2 patients were administered ganciclovir/penciclovir combined with human immunoglobulin for the treatment of GBS caused by HPV B19 infection, with good results, suggesting that the ganciclovir/human immunoglobulin combination has the potential for use in the treatment of patients with HPV B19 clinical infection.…”